C3 and systemic lupus erythematosus: We performed ROC curve analysis based on low level complements (low levels of C3 and/or C4) combined with positive anti-dsDNA Ab to assess the efficiency of conventional biomarkers in predicting active lupus (SLEDAI ≥ 5) (Figure 4(a)).